Skip to main content
padlock icon - secure page this page is secure

Genetic Engineering in Allotransplantation of Vascularized Organs

Buy Article:

$63.00 + tax (Refund Policy)

Transplantation offers a unique opportunity for gene transfer into allografts before grafting. After organ retrieval, the cold ischemic period renders organs available for manipulation and gene transfer. Local expression of protective or immunomodulatory molecules within the graft environment offers a better local bioavailability of bioreagents and potentially less systemic side effects. Protection against ischemia-reperfusion injury, acute and / or chronic rejection without significant side effects would be a major breakthrough in transplant research. However, protocols of transfection adapted to the transplant setting and control of gene expression must be clearly evaluated before going to clinical trials. The first part of this review deals with gene transfer techniques into the allograft, emphasizing particular transplant conditions that are encountered and that must be respected when designing protocols for gene transfer experiments. The second part deals with specific therapeutic strategies to protect and prolong allograft survival.
No References
No Citations
No Supplementary Data
No Article Media
No Metrics

Keywords: Allotransplantation; Anti-Oxidative Molecules; Cationic Polymers; Costimulatory Signals; Immunosuppressive Cytokines; hyperbaric administration; hypercholesterolemia; immunomodulatory molecules

Document Type: Review Article

Publication date: 01 February 2002

  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
X
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more